Move to ban fixed-dose combinations a culmination of efforts to free market from irrational drugsThe US Food & Drug Administration has favoured use of FDCs for HIV treatments, but approval process is rigorous.
TB treatment could be shortened, show trialsThe effectiveness of the four-month regimen was proved on the basis of recurrence levels, number of patients testing negative in sputum sme...
- World TB day: Need to raise public spend on clinical trials & find innovative ways to incentivise R&D
March 24 is World TB day. It commemorates the discovery of Tuberculosis (TB) bacillus in 1883 by Dr Robert Koch as the cause of tuberculosi...
- Lupin signs strategic deal with Brazilian firm Farmanguinhos
Pharma Major, Lupin Ltd today announced that it has entered into an agreement with Farmanguinhos for the supply of its 4 in 1 combination d...
- Lupin inks pact with Brazil for TB drug supply for 5 yrs
Drug firm Lupin today said it has signed an agreement with Brazil to supply its four-in-one combination drug to treat tuberculosis.
- Mid-cap pharma firms focus on LatAm market
Lupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...
Only 33 drugs to stay under price controlIT will be a mixed bag for the pharma industry. Pharma multinationals and domestic drug majors are expected to gain enormously with the che...